Watersoluble polymers in medicine

10.1351/pac196816020201

10.1080/15583726608085355

Lee H., 1971, Handbook for Surgery and Artificial Organs.

10.1002/ange.19700821002

10.1002/anie.197003321

Zaharko D. S., 1979, Methods Cancer Res., 16, 347

10.1016/0014-2964(78)90167-6

Gregoriadis G., 1979, Drug Carriers in Biology and Medicine

Goldberg E., Targeted Drugs

10.1002/ange.19810930405

10.1002/anie.198103051

10.1007/3-540-12796-8_10

Speiser P., 1981, Österreichische Apotheker‐Zeitung, 35, 805

(b)W.Klesse Dissertation University Mainz1982;

(c)G.Hörpel Dissertation University Mainz1983.

10.1002/ange.19810930124

10.1002/anie.198100901

10.1515/bchm2.1954.297.1.149

10.1515/znb-1955-0106

10.1070/RC1964v033n09ABEH001468

10.1021/jm00330a030

Ringsdorf H., 1967, Strahlentherapie, 132, 627

Gresser A., 1963, Dtsch. Med. Wochenschr., 88, 2217

10.1002/polc.5070510111

Ringsdorf H., 1977, Polymeric Delivery Systems. Midl. Macromol. Monogr.

Ryser H. J. P., 1967, Proc. Int. Congr. Pharmacol. 4th, 3, 96

10.1126/science.159.3813.390

10.1038/194255a0

Trouet A., 1977, Polymeric Delivery Systems. Midl. Macromol. Monogr., 157

10.1016/0006-2952(74)90174-9

Couvreur P., 1980, J. Pharm. Belg., 35, 51

Tanguary A. C., 1974, Controlled Release of Biologically, 10.1007/978-1-4684-7239-4

10.1351/pac197646020103

Langer R., 1982, Polymeric Delivery Systems Designing Constant Rate Systems, A. C. S. Symp. Ser., 186, 95

Korn E. D., 1975, MTP INT. Rev. Sci. Biochem. Ser. I, 2, 1

Shen W. C., 1981, Selective Protection aganist the Cytotoxicity of Methotrexate and Poly‐L‐Lysine by Thiamine Pyrophosphate, Heparin and Leucovorin, Biochem. Biophys. Res. Commun., 102, 1048

Trouet A., 1980, Bull. Mem. Acad. R. Med. Belg., 135, 261

10.1016/0006-291X(81)91644-2

10.1093/jnci/60.2.379

10.1073/pnas.79.2.626

10.1016/0079-6700(83)90005-9

(b)J.KopecekinJ. M.Anferson S. W.Kim Recent Advances in Drug Delivery SystemsEds. Plenum Press New York in press.

Osborne J. C., The Plasma Lipoproteins, Adv. Protein Chem., 1977

10.1002/macp.1979.020021979113

Goldberg E., 1983, Targeted Drugs

10.1007/978-1-4684-4241-0

10.1007/BF00284124

Peter G., 1976, Cancer Treat. Rep., 60, 429

10.1002/macp.1979.021800438

L. C.Erickson G.Hörpel K. W.Kohn H.Ringsdorf D. S.Zaharko in preparation.

Weinstein J. N., 1984, Cancer Treat. Rep., 68, 127

10.1038/nbt1283-869

10.1056/NEJM197609232951305

10.1056/NEJM197609302951406

10.1002/macp.1984.020061984119

10.1002/anie.198009381

10.1016/0005-2736(80)90304-1

10.1016/0005-2736(83)90347-4

10.1021/ja00541a078

10.1021/ja00348a009

10.1021/ja00366a014

10.1021/ja00343a011

10.1021/ja00318a013

10.1002/pol.1981.130190302

10.1016/0009-3084(83)90078-6

10.1016/0009-3084(83)90039-7

I. J.Goldstein:Carbohydrate‐Protein Interactions A. C. S. Symp. Ser. 88(1979).

10.1016/S0021-9258(17)30071-6

10.1016/S0021-9258(18)43638-1

10.1002/ange.19810930125

10.1002/anie.198100911

H.Bader Diplomarbeit University Mainz 1981.

10.1002/marc.1982.030030902

10.1016/S0006-3495(84)84215-0

R.Elbert Th.Folda H.Ringsdorf in preparation.

Th.Folda Dissertation University Mainz1984.

Th.Folda J.Lando H.Ringsdorf in preparation.

10.1038/scientificamerican0577-62

Andresen R., 1983, Exp. Hematol., 11, 564